[Report of 250 Pages] By 2032, it is anticipated that the intracardiac imaging market will be worth US$ 1256.3 million. An increase in the prevalence of arrhythmia, which affects about 500,000 people worldwide, is what is driving the growth of the global intracardiac imaging market.
The global intracardiac imaging market is anticipated to reach US$ 661.8 Million in 2022 and is expected to grow at a CAGR of 6% from 2022 to 2032, according to FMI Analysts.
Intracardiac Imaging Market Overview
There has been a significant process in the file of coronary imaging in the past decade. The non-fluoroscopic intracardiac imaging is increasingly used to guide interventional electrophysiology therapeutic procedures. This is primarily due to the advantage of real-time, direct observation and improved procedure guidance that the intracardiac imaging devices offer over the fluoroscopy methods.
Minimally invasive and trans catheter procedures are becoming more complex, this increased the demand for more detailed anatomical imaging. Devices such as intracardiac echo, transthoracic echo, intravascular ultrasound and optical coherence tomography are some of the devices that are seeing increased use for detailed navigation procedures and to reduce radiation dose from use of angiographic fluoroscopy procedures such as interventional valve placement, cardiac tumour ablation, coronary stent and imaging among others.
These devices are often used to form 3D and 4D images with higher details. One of the main focus of players in the intracardiac imaging market is to develop high definition images of the internal structures of the heart. Some of the key products include, iLab Ultrasound Imaging System, Vivid, Acuson X300 Ultrasound System, ViewMate Z Ultrasound Console, Acist, Polaris Imaging System and C7XR and Ilumien among others. Specialized catheters are also available for each of these systems such as, VIewFlex PLUS ICE catheter, AcuNav 8 French, AcuNav 10 French, Atlantis ICE, Ultra ICE, Ocelot, Kodama, OptiCross IVUS, and TVC Insight.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-9661
Intracardiac imaging Market: Drivers and Restraints
Increase in cardiovascular diseases, reduced risk of exposure to radiation, increase in adoption of interventional technology, rise in number of interventional cardiology procedures, favourable reimbursements, increase in number of Cath labs and cardiac imaging procedures are some of the factors that drive the growth of the intracardiac imaging market. However, highly regulated and stringent approval process of devices, high cost of the device and accessories, high cost of procedure are some of the factors that may hinder the growth of the intracardiac imaging market through the forecast period.
Intracardiac imaging Market: Overview
The intracardiac imaging market is a relatively new market. Most of the technologies in the intracardiac imaging market are Ultrasound based. The adoption of intracardiac imaging is expected to increase significantly through the forecast period owing to favourable reimbursements, and advantages over the current interventional radiology procedures such as reduced unnecessary radiation exposure. However there are not many players in the intracardiac imaging market primarily due to the stringent approval process of devices across the world. A number of small companies are also key players in the intracardiac imaging market.
Intracardiac imaging Market: Regional Outlook
North America and Europe is expected to lead the Intracardiac imaging market owing to the rise in adoption of interventional technology, and increased research funding in the region. Increased cardiovascular diseases in the developed nations is one of the factors that drive the growth of the Intracardiac imaging market in North America and Europe Regions. Asia pacific, is expected to have a significant growth rate due to the rise in ageing population and increase in number of cardiovascular diseases, as well as rising healthcare spending and increase in number of interventional procedures in the region.
For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-9661
Intracardiac imaging Market: Key Players
Some of the Key players in the Intracardiac imaging market include, Boston Scientific, GE Healthcare, Siemens Healthcare, Acist Medical Systems, InfraReDx Inc, Avinger and St. Jude Medical.
The report covers exhaustive analysis on:
- Intracardiac imaging Market Segments
- Intracardiac imaging Market Dynamics
- Intracardiac imaging Market Size
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
The regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Europe (Germany, Italy, France, U.K, Spain, Russia, Rest of Europe)
- East Asia (China, Japan, South Korea)
- South Asia (India, Malaysia, Thailand, Indonesia, Rest of South Asia)
- Oceania (Australia & New Zealand)
- The Middle East and Africa (GCC, S. Africa, N. Africa, Rest of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Key Segments Profiled in the Intracardiac Imaging Market
By Product Type:
- Intracardiac Echo
- Transthoracic Echo
- Transesophageal (TEE) imaging
- Intravascular ultrasound (IVUS)
- Optical coherence tomography (OCT)
By End User:
- Hospitals
- Diagnostics Imaging Centers
- Cath Labs
- Academic and Research Institutes
Have a Look at Related Research Reports in the Healthcare Domain:
Synchrotron Instrumentation Market Size: According to Future Market Insights research, during the projected period, the global synchrotron instrumentation market is expected to grow at a CAGR of 5.6%. The market value is projected to increase from US$ 1.05 Billion in 2023 to US$ 1.80 Billion by 2033.
Dermatology Excimer Lasers Market Share: According to Future Market Insights research, during the projected period, the global dermatology excimer lasers market is expected to grow at a CAGR of 11.4%. The market value is projected to increase from US$ 87.7 Million in 2023 to US$ 258.4 Million by 2033.
Image Guided Systems Market Growth: The Global Image Guided Systems Market was valued at US$ 7.23 Billion in 2022 and is expected to reach US$ 17.41 Billion by 2033.
About FMI:
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
